Search

Your search keyword '"Begaud, Bernard"' showing total 202 results
Start Over Author "Begaud, Bernard"
202 results on '"Begaud, Bernard"'

1. The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

Author

Fusaroli, Michele, Salvo, Francesco, Begaud, Bernard, AlShammari, Thamir M., Bate, Andrew, Battini, Vera, Brueckner, Andreas, Candore, Gianmario, Carnovale, Carla, Crisafulli, Salvatore, Cutroneo, Paola Maria, Dolladille, Charles, Drici, Milou-Daniel, Faillie, Jean-Luc, Goldman, Adam, Hauben, Manfred, Herdeiro, Maria Teresa, Mahaux, Olivia, Manlik, Katrin, Montastruc, François, Noguchi, Yoshihiro, Norén, G. Niklas, Noseda, Roberta, Onakpoya, Igho J., Pariente, Antoine, Poluzzi, Elisabetta, Salem, Myriam, Sartori, Daniele, Trinh, Nhung T. H., Tuccori, Marco, van Hunsel, Florence, van Puijenbroek, Eugène, Raschi, Emanuel, and Khouri, Charles

Published
2024
Full Text
View/download PDF

2. The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

Author

Fusaroli, Michele, Salvo, Francesco, Begaud, Bernard, AlShammari, Thamir M., Bate, Andrew, Battini, Vera, Brueckner, Andreas, Candore, Gianmario, Carnovale, Carla, Crisafulli, Salvatore, Cutroneo, Paola Maria, Dolladille, Charles, Drici, Milou-Daniel, Faillie, Jean-Luc, Goldman, Adam, Hauben, Manfred, Herdeiro, Maria Teresa, Mahaux, Olivia, Manlik, Katrin, Montastruc, François, Noguchi, Yoshihiro, Norén, G. Niklas, Noseda, Roberta, Onakpoya, Igho J., Pariente, Antoine, Poluzzi, Elisabetta, Salem, Myriam, Sartori, Daniele, Trinh, Nhung T. H., Tuccori, Marco, van Hunsel, Florence, van Puijenbroek, Eugène, Raschi, Emanuel, and Khouri, Charles

Published
2024
Full Text
View/download PDF

3. What should be done to combat misinformation about health products?

Author

Micallef, Joëlle, Maisonneuve, Hervé, Muller, Sophie, Molimard, Mathieu, Bégaud, Bernard, Cabut, Sandrine, Daban, Mina, Drici, Milou-Daniel, Gatignol, Chantal, Grumblat, Anne, Guaspare-Cartron, Catherine, Lasserre, Bruno, Mebarki, Adel, Pons, Catherine, Prabonnaud, Frédérique, Raynaud, Catherine, and Saint-Lary, Olivier

Published
2024
Full Text
View/download PDF

20. Relative Risks from Case-Population Data

Author

Moore, Nicholas, Gulmez, Sinem Ezgi, Blin, Patrick, Lassalle, Régis, Jove, Jeremy, Théophile, Hélène, Bégaud, Bernard, Larrey, Dominique, and Bénichou, Jacques

Published
2013

21. Authors' reply

Author

de Gage, Sophie Billioti, Bégaud, Bernard, and Pariente, Antoine

Published
2012

33. Exploratory Clinical Trials: Implementation Modes & Guidelines, Scope and Regulatory Framework

Author

Abiteboul, Michel, Bégaud, Bernard, Behier, Jehan-Michel, Belorgey, Chantal, Chauvin, Bénédicte, Cournot, Antoine, Defrance, Rémy, Demarez, Jean-Paul, Devilliers, Élisabeth, Diebolt, Vincent, Diquet, Bertrand, Donazzolo, Yves, Echemann, Muriel, Francillon, Alain, Funck-Brentano, Christian, Genissel, Patrick, Houedé, Nadine, Husson, Jean-Marc, Lefevre, Philippe, Macquin-Mavier, Isabelle, Marchenay, Brigitte, Marey, Christine, Negres-Pages, Laurence, Pickering, Gisèle, Pitel, Séverine, Plattner, Valérie, Roy, Christine, Sibille, Michel, Simon, Nicolas, Thalamas, Claire, Tremblay, Dominique, and Waegemans, Tony

Published
2009
Full Text
View/download PDF

34. Essais cliniques exploratoires : quelles modalités de mise en œuvre, recommandations de mise en œuvre, champ d’application, cadre réglementaire ?

Author

Abiteboul, Michel, Bégaud, Bernard, Behier, Jehan-Michel, Belorgey, Chantal, Chauvin, Bénédicte, Cournot, Antoine, Defrance, Rémy, Demarez, Jean-Paul, Devilliers, Élisabeth, Diebolt, Vincent, Diquet, Bertrand, Donazzolo, Yves, Echemann, Muriel, Francillon, Alain, Funck-Brentano, Christian, Genissel, Patrick, Houedé, Nadine, Husson, Jean-Marc, Lefevre, Philippe, Macquin-Mavier, Isabelle, Marchenay, Brigitte, Marey, Christine, Negres-Pages, Laurence, Pickering, Gisèle, Pitel, Séverine, Plattner, Valérie, Roy, Christine, Sibille, Michel, Simon, Nicolas, Thalamas, Claire, Tremblay, Dominique, and Waegemans, Tony

Published
2009
Full Text
View/download PDF

39. Medicine misuse: A systematic review and proposed hierarchical terminology

Author

Singier, Allison, Noize, Pernelle, Berdai, D., Daveluy, Amelie, Arnaud, Mickael, Molimard, Mathieu, Begaud, Bernard, Salvo, Francesco, Admin, Oskar, Bordeaux population health (BPH), and Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)

Subjects
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Abstract

AIMS: Although medicine misuse is a public health issue, it has multiple meanings in the medical literature. This study aimed to characterize, classify and identify the most appropriate definitions of medicine misuse. METHODS: A systematic review was performed in Medline, ISI Web of Science, SocINDEX, PsycInfo, PsycArticles and Psychological and Behavioral Sciences Collection, using keywords related to "misuse", "appropriateness" and "medicine" between 1 November 2008 and 25 August 2020. Additional searches were conducted in websites of regulatory agencies and public health institutions. Two authors independently selected studies providing both definitions and examples of misuse, while a third resolved disagreements. Definitions were used to propose a hierarchical classification based on initiator, intent, purpose and context of medicine misuse. The study is registered on PROSPERO: CRD42018115789. RESULTS: Of 3404 identified records, 51 were included. A total of 71 definitions and 74 examples of misuse were retrieved. When the prescriber is initiator and according to intent, potential medicine misuse referred to "intentional or unintentional prescribing not in line with clinical evidence". Based on context, they could prescribe medicines not clinically justified, i.e. overprescribing, or prescribe indicated medicines incorrectly, i.e. misprescribing. Among other groups of definitions, those overlapping with drug abuse or medication use errors were considered out-of-scope. CONCLUSION: This systematic review provides a comprehensive overview of the terms and definitions used to characterize medicine misuse and could serve as a basis for a terminology that makes clear distinctions between misuse, abuse and errors.

Published
2020

40. Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital

Author

Grenouillet-Delacre, Marieke, Verdoux, Helene, Moore, Nicholas, Haramburu, Francoise, Miremont-Salame, Ghada, Etienne, Gabriel, Robinson, Philip, Gruson, Didier, Hilbert, Gilles, Gabinski, Claude, Begaud, Bernard, and Molimard, Mathieu

Subjects
Drugs -- Health aspects -- Research, Hospital patients -- Health aspects -- Research, Health care industry
Abstract

Objective: To assess the characteristics of life-threatening adverse drug reactions in patients admitted to medical intensive care unit and to define those that could facilitate early identification. Design: A prospective 6-month observational study. Patients: Of the 436 admissions to the teaching hospital medical intensive care unit, all patients aged over 15 years and who had received documented drug treatment were included (n = 405). Measurements: Characteristics of patients [age, gender, underlying diseases, organ failure(s), drugs taken, Severity Acute Physiologic Score II, length of stay, outcome at discharge] were prospectively collected using a standardised questionnaire. A panel of experts assessed putative serious adverse drug reaction(s) for each drug taken and each organ failure at admission by using a standardised causality assessment method. Characteristics of patients with and without serious adverse drug reactions at admission were compared using univariate and then stepwise descending multivariate logistic regression. Results: Of the 405 patients included, 111 (27.4%) presented an adverse drug reaction leading to organ failure. In 48% of cases adverse drug reactions were preventable, 23% were undiagnosed and 19% contributed to death. Age over 75 years [odds ratio (OR) 2.25; 95% confidence interval (CI) 1.15-4.38; p = 0.02], having more than three drugs (OR 6.90; 95% CI 1.44-33.00; p = 0.02) and a diagnosis of haematological malignancy (OR 6.19; 95% CI 2.07-18.53; p = 0.001) were independently associated with serious adverse drug reactions. Conclusions: Preventable life-threatening adverse drug reactions were frequently involved in organ failure at admission to medical intensive care; many of them had not been identified. Keywords Serious adverse drug reaction * Organ failure * Intensive care unit, Introduction Adverse drug reactions (ADRs) are frequent and can occur during hospitalisation leading to either hospitalisation or prolongation of stay [1, 2]. Serious ADRs are fatal in 5% of cases, [...]

Published
2007
Full Text
View/download PDF

47. Vaccinations and multiple sclerosis

Author

Begaud, Bernard, Alperovitch, Annick, Hanslik, Thomas, Viboud, Cecile, Flahault, Antoine, Gout, Olivier, Sturkenboom, Miriam C.J.M., Fourrier, Annie, Buttinelli, Carla, Salvetti, Marco, Ristori, Giovanni, Hostetler, Larry, Ascherio, Alberto, Zhang, Shumin M., Walker, Alexander M., Confavreux, Christian, Suissa, Samy, and Saddier, Patricia

Subjects
Hepatitis B vaccine -- Adverse and side effects, Multiple sclerosis -- Risk factors
Published
2001

Catalog

Books, media, physical & digital resources
See catalog results